rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2010-10-5
|
pubmed:abstractText |
HER2/neu status of tumor cells at metastatic sites in patients with advanced disease may differ from that of the primary tumor. Assessing the presence of target antigens on circulating tumor cells (CTCs) might affect treatment choice.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1938-0666
|
pubmed:author |
pubmed-author:AdamoliLauraL,
pubmed-author:BotteriEdoardoE,
pubmed-author:CasadioChiaraC,
pubmed-author:CassatellaMaria CristinaMC,
pubmed-author:CuriglianoGiuseppeG,
pubmed-author:EspositoAngelaA,
pubmed-author:GoldhirschAronA,
pubmed-author:MinchellaIdaI,
pubmed-author:MunzoneElisabettaE,
pubmed-author:NoléFrancoF,
pubmed-author:SandriMaria TeresaMT,
pubmed-author:ZorzinoLauraL
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
392-7
|
pubmed:meshHeading |
pubmed-meshheading:20920984-Adult,
pubmed-meshheading:20920984-Aged,
pubmed-meshheading:20920984-Breast Neoplasms,
pubmed-meshheading:20920984-Disease-Free Survival,
pubmed-meshheading:20920984-Female,
pubmed-meshheading:20920984-Gene Expression,
pubmed-meshheading:20920984-Genes, erbB-2,
pubmed-meshheading:20920984-Humans,
pubmed-meshheading:20920984-Kaplan-Meier Estimate,
pubmed-meshheading:20920984-Middle Aged,
pubmed-meshheading:20920984-Neoplasm Metastasis,
pubmed-meshheading:20920984-Neoplastic Cells, Circulating,
pubmed-meshheading:20920984-Prospective Studies,
pubmed-meshheading:20920984-Receptor, erbB-2
|
pubmed:year |
2010
|
pubmed:articleTitle |
Changes of HER2 status in circulating tumor cells compared with the primary tumor during treatment for advanced breast cancer.
|
pubmed:affiliation |
Division of Medical Oncology, European Institute of Oncology, Milan, Italy. elisabetta.munzone@ieo.it
|
pubmed:publicationType |
Journal Article
|